Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

HIV Infection

Free Subscription Articles published in Lancet Retrieve available abstracts of 107 articles: HTML format

Single Articles

August 2024
1. KIZITO S, Nabayinda J, Nabunya P, Ssewamala FM, et al
   HIV and tuberculosis in Uganda: are we neglecting poverty?
   Lancet. 2024;404:844-845.
   PubMed    
   
   
   
2. BASSEY AE
   The health of migrants at the intersection of mpox and HIV.
   Lancet. 2024 Aug 23:S0140-6736(24)01753-7. doi: 10.1016/S0140-6736(24)01753.
   PubMed    
   
   
   
3. MODY A, Sohn AH, Iwuji C, Tan RKJ, et al
   The battle against paediatric HIV is far from over - Authors' reply.
   Lancet. 2024;404:522-523.
   PubMed    
   
   
   
4. VAN DE PERRE P, Tylleskar T
   The battle against paediatric HIV is far from over.
   Lancet. 2024;404:522.
   PubMed    
   
   
   
5. NABAYINDA J, Kizito S, Nagawa A, Ssewamala FM, et al
   Reducing HIV in young women in Uganda: the need for autonomy.
   Lancet. 2024;404:519-520.
   PubMed    
   
   
   
6. SALEEM SM, Haq Z
   Bridging gaps in vertical transmission of HIV, syphilis, and hepatitis B in India.
   Lancet. 2024;404:428-429.
   PubMed    
   
   
   July 2024
7. KIRBY T
   Beatriz Grinsztejn: leading Brazil's response to HIV.
   Lancet. 2024;404:233.
   PubMed    
   
   
   May 2024
8. JAFFAR S
   Integrated HIV, diabetes, and hypertension care in sub-Saharan Africa - Authors' reply.
   Lancet. 2024;403:2292.
   PubMed    
   
   
   
9. CAI S, Xu Z, Zhao Y, Zuhlke L, et al
   Integrated HIV, diabetes, and hypertension care in sub-Saharan Africa.
   Lancet. 2024;403:2291.
   PubMed    
   
   
   
10. HAVLIR D, Kamya MR, Petersen M
    Integrated HIV, diabetes, and hypertension care in sub-Saharan Africa.
    Lancet. 2024;403:2291-2292.
    PubMed    
    
    
    
11. MAERTENS GN, Purcell DFJ, Rosadas C, Bradshaw D, et al
    Why not eliminate HTLV-1 while eliminating HIV-1?
    Lancet. 2024;403:2288-2289.
    PubMed    
    
    
    
12. 
    The HIV response beyond 2030: preparing for decades of sustained HIV epidemic control in eastern and southern Africa.
    Lancet. 2024 May 20:S0140-6736(24)00980-2. doi: 10.1016/S0140-6736(24)00980.
    PubMed    
    
    
    
13. LEWNARD JA, Charani E, Gleason A, Hsu LY, et al
    Burden of bacterial antimicrobial resistance in low-income and middle-income countries avertible by existing interventions: an evidence review and modelling analysis.
    Lancet. 2024 May 20:S0140-6736(24)00862-6. doi: 10.1016/S0140-6736(24)00862.
    PubMed     Abstract available
    
    
    
14. MENDELSON M, Lewnard JA, Sharland M, Cook A, et al
    Ensuring progress on sustainable access to effective antibiotics at the 2024 UN General Assembly: a target-based approach.
    Lancet. 2024 May 20:S0140-6736(24)01019-5. doi: 10.1016/S0140-6736(24)01019.
    PubMed     Abstract available
    
    
    April 2024
15. TUTLAM NT, Kizito S, Liyew TW, Ssewamala FM, et al
    HIV among refugee youth in Uganda: unmasking the crisis.
    Lancet. 2024;403:1536-1537.
    PubMed    
    
    
    
16. 
    Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a sys
    Lancet. 2024 Apr 15:S0140-6736(24)00757-8. doi: 10.1016/S0140-6736(24)00757.
    PubMed     Abstract available
    
    
    
17. 
    Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.
    Lancet. 2024 Apr 3:S0140-6736(24)00367-2. doi: 10.1016/S0140-6736(24)00367.
    PubMed     Abstract available
    
    
    March 2024
18. BEYRER C, Kamarulzaman A, Isbell M, Amon J, et al
    Under threat: the International AIDS Society-Lancet Commission on Health and Human Rights.
    Lancet. 2024 Mar 20:S0140-6736(24)00302-7. doi: 10.1016/S0140-6736(24)00302.
    PubMed    
    
    
    
19. WATTS G
    Andrew Kerkhoff: award-winning TB and HIV physician-scientist.
    Lancet. 2024 Mar 15:S0140-6736(24)00539-7. doi: 10.1016/S0140-6736(24)00539.
    PubMed    
    
    
    
20. KANKASA C, Mennecier A, Sakana BLD, Moles JP, et al
    Optimised prevention of postnatal HIV transmission in Zambia and Burkina Faso (PROMISE-EPI): a phase 3, open-label, randomised controlled trial.
    Lancet. 2024 Mar 11:S0140-6736(23)02464-9. doi: 10.1016/S0140-6736(23)02464.
    PubMed     Abstract available
    
    
    
21. MUTALE W, Herce ME
    Closing the gap in paediatric HIV infections: how available tools and technology can accelerate progress towards ending AIDS by 2030.
    Lancet. 2024 Mar 11:S0140-6736(24)00366-0. doi: 10.1016/S0140-6736(24)00366.
    PubMed    
    
    
    
22. 
    Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950-2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden
    Lancet. 2024 Mar 8:S0140-6736(24)00476-8. doi: 10.1016/S0140-6736(24)00476.
    PubMed     Abstract available
    
    
    February 2024
23. JOHNSTONE F
    Picture an epidemic: contemporary culture and HIV.
    Lancet. 2024 Feb 13:S0140-6736(24)00252-6. doi: 10.1016/S0140-6736(24)00252.
    PubMed    
    
    
    January 2024
24. PURIM E
    Full decriminalisation of the sex industry would not protect the health of prostitutes.
    Lancet. 2024;403:351-352.
    PubMed    
    
    
    
25. KAMYA MR, Kakuru A, Dorsey G
    Dihydroartemisinin-piperaquine for prevention of malaria in pregnant women living with HIV.
    Lancet. 2024 Jan 12:S0140-6736(24)00048-5. doi: 10.1016/S0140-6736(24)00048.
    PubMed    
    
    
    
26. BARSOSIO HC, Madanitsa M, Ondieki ED, Dodd J, et al
    Chemoprevention for malaria with monthly intermittent preventive treatment with dihydroartemisinin-piperaquine in pregnant women living with HIV on daily co-trimoxazole in Kenya and Malawi: a randomised, double-blind, placebo-controlled trial.
    Lancet. 2024 Jan 12:S0140-6736(23)02631-4. doi: 10.1016/S0140-6736(23)02631.
    PubMed     Abstract available
    
    
    
27. KIRBY T
    Steady but variable progress towards global HIV targets.
    Lancet. 2024;403:16-17.
    PubMed    
    
    
    December 2023
28. KAMARULZAMAN A, Maleche A, Beyrer C
    Still relevant: the 75th anniversary of the Universal Declaration of Human Rights.
    Lancet. 2023;402:2171-2173.
    PubMed    
    
    
    November 2023
29. KIRBY T
    Bruce Richman: building the U=U movement for HIV prevention.
    Lancet. 2023 Nov 30:S0140-6736(23)02699-5. doi: 10.1016/S0140-6736(23)02699.
    PubMed    
    
    
    
30. MODY A, Sohn AH, Iwuji C, Tan RKJ, et al
    HIV epidemiology, prevention, treatment, and implementation strategies for public health.
    Lancet. 2023 Nov 30:S0140-6736(23)01381-8. doi: 10.1016/S0140-6736(23)01381.
    PubMed     Abstract available
    
    
    
31. THE LANCET
    Preventing healers from becoming killers.
    Lancet. 2023;402:1805.
    PubMed    
    
    
    
32. NUNEZ I, Valdes-Ferrer SI
    Classifying necrotising mpox as an AIDS-defining condition - Authors' reply.
    Lancet. 2023;402:1752.
    PubMed    
    
    
    
33. MITJA O, Paredes R, Cabtree B, Orkin C, et al
    Classifying necrotising mpox as an AIDS-defining condition.
    Lancet. 2023;402:1751-1752.
    PubMed    
    
    
    
34. WONG M, Damon IK, Zucker J, Foote MMK, et al
    ART initiation for people living with HIV with severe mpox.
    Lancet. 2023;402:1750.
    PubMed    
    
    
    
35. KASPER T, Yamey G, Dwyer S, McDade KK, et al
    Rethinking how development assistance for health can catalyse progress on primary health care.
    Lancet. 2023 Nov 10:S0140-6736(23)01813-5. doi: 10.1016/S0140-6736(23)01813.
    PubMed     Abstract available
    
    
    October 2023
36. MEMISH ZA, Blumberg L, Al-Maani AS, Baru R, et al
    Moving cholera vaccines ahead of the epidemic curve.
    Lancet. 2023 Oct 17:S0140-6736(23)02244-4. doi: 10.1016/S0140-6736(23)02244.
    PubMed    
    
    
    
37. KIVUYO S, Birungi J, Okebe J, Wang D, et al
    Integrated management of HIV, diabetes, and hypertension in sub-Saharan Africa (INTE-AFRICA): a pragmatic cluster-randomised, controlled trial.
    Lancet. 2023;402:1241-1250.
    PubMed     Abstract available
    
    
    
38. BALDEH M, Kizito S
    Call to action: HIV among adolescents in Sierra Leone.
    Lancet. 2023;402:1240.
    PubMed    
    
    
    
39. KISIGO GA, Peck RN
    Integrating HIV, hypertension, and diabetes primary care in Africa.
    Lancet. 2023;402:1211-1213.
    PubMed    
    
    
    September 2023
40. KAVANAGH MM, Wenham C, Massard da Fonseca E, Helfer LR, et al
    Increasing compliance with international pandemic law: international relations and new global health agreements.
    Lancet. 2023 Sep 4:S0140-6736(23)01527-1. doi: 10.1016/S0140-6736(23)01527.
    PubMed     Abstract available
    
    
    August 2023
41. ZHU DT, Friedman J, Bourgois P, Montero F, et al
    The emerging fentanyl-xylazine syndemic in the USA: challenges and future directions.
    Lancet. 2023 Aug 24:S0140-6736(23)01686-0. doi: 10.1016/S0140-6736(23)01686.
    PubMed    
    
    
    
42. THE LANCET
    Ending the HIV pandemic: preparing for the future.
    Lancet. 2023;402:585.
    PubMed    
    
    
    
43. MARTIN CA, Medisauskaite A, Gogoi M, Teece L, et al
    Discrimination, feeling undervalued, and health-care workforce attrition: an analysis from the UK-REACH study.
    Lancet. 2023 Aug 18:S0140-6736(23)01365-X. doi: 10.1016/S0140-6736(23)01365.
    PubMed    
    
    
    
44. 
    Cause-specific mortality by county, race, and ethnicity in the USA, 2000-19: a systematic analysis of health disparities.
    Lancet. 2023 Aug 3:S0140-6736(23)01088-7. doi: 10.1016/S0140-6736(23)01088.
    PubMed     Abstract available
    
    
    July 2023
45. BROYLES LN, Luo R, Boeras D, Vojnov L, et al
    The risk of sexual transmission of HIV in individuals with low-level HIV viraemia: a systematic review.
    Lancet. 2023 Jul 21:S0140-6736(23)00877-2. doi: 10.1016/S0140-6736(23)00877.
    PubMed     Abstract available
    
    
    
46. BEKKER LG, Smith P, Ntusi NAB
    HIV is sexually untransmittable when viral load is undetectable.
    Lancet. 2023 Jul 21:S0140-6736(23)01519-2. doi: 10.1016/S0140-6736(23)01519.
    PubMed    
    
    
    
47. SHARMA DC
    Ethnic conflict hampering health services in Manipur, India.
    Lancet. 2023;402:94.
    PubMed    
    
    
    June 2023
48. 
    The unfinished agenda of communicable diseases among children and adolescents before the COVID-19 pandemic, 1990-2019: a systematic analysis of the Global Burden of Disease Study 2019.
    Lancet. 2023 Jun 29:S0140-6736(23)00860-7. doi: 10.1016/S0140-6736(23)00860.
    PubMed     Abstract available
    
    
    May 2023
49. FLAHAULT A, Calmy A, Costagliola D, Drapkina O, et al
    No time for complacency on COVID-19 in Europe.
    Lancet. 2023 May 22:S0140-6736(23)01012-7. doi: 10.1016/S0140-6736(23)01012.
    PubMed    
    
    
    
50. ZEGGAGH J, Ferraris O, Salmona M, Tarantola A, et al
    Second clinical episode of hMPX virus in a man having sex with men.
    Lancet. 2023;401:1610.
    PubMed    
    
    
    April 2023
51. O'SHEA J, Daskalakis D, Brooks JT
    The emergence of mpox as an HIV-related opportunistic infection.
    Lancet. 2023;401:1264.
    PubMed    
    
    
    
52. WEBSTER P
    PEPFAR at 20.
    Lancet. 2023;401:1145-1146.
    PubMed    
    
    
    
53. NKENGASONG J, Ratevosian J
    Legal and policy barriers for an effective HIV/AIDS response.
    Lancet. 2023 Apr 5:S0140-6736(23)00729-8. doi: 10.1016/S0140-6736(23)00729.
    PubMed    
    
    
    March 2023
54. NUNEZ I, Valdes-Ferrer SI
    Fulminant mpox as an AIDS-defining condition: useful or stigmatising?
    Lancet. 2023;401:881-884.
    PubMed    
    
    
    
55. WATTS G
    Bern-Thomas Nyang'wa: getting things done in TB and HIV.
    Lancet. 2023 Mar 17:S0140-6736(23)00576-7. doi: 10.1016/S0140-6736(23)00576.
    PubMed    
    
    
    
56. MADANITSA M, Barsosio HC, Minja DTR, Mtove G, et al
    Effect of monthly intermittent preventive treatment with dihydroartemisinin-piperaquine with and without azithromycin versus monthly sulfadoxine-pyrimethamine on adverse pregnancy outcomes in Africa: a double-blind randomised, partly placebo-controlle
    Lancet. 2023 Mar 10:S0140-6736(22)02535-1. doi: 10.1016/S0140-6736(22)02535.
    PubMed     Abstract available
    
    
    February 2023
57. MITJA O, Alemany A, Marks M, Lezama Mora JI, et al
    Mpox in people with advanced HIV infection: a global case series.
    Lancet. 2023 Feb 20:S0140-6736(23)00273-8. doi: 10.1016/S0140-6736(23)00273.
    PubMed     Abstract available
    
    
    January 2023
58. KIRBY T, Thornber-Dunwell M
    10 years on-high-risk practices on the London gay scene.
    Lancet. 2023;401:94-95.
    PubMed    
    
    
    December 2022
59. BYANYIMA W, Lauterbach K, Kavanagh MM
    Community pandemic response: the importance of action led by communities and the public sector.
    Lancet. 2022 Dec 14:S0140-6736(22)02575-2. doi: 10.1016/S0140-6736(22)02575.
    PubMed    
    
    
    
60. SAMARASEKERA U
    Pakistan's growing HIV epidemic.
    Lancet. 2022;400:2031.
    PubMed    
    
    
    November 2022
61. THORNHILL JP, Palich R, Ghosn J, Walmsley S, et al
    Human monkeypox virus infection in women and non-binary individuals during the 2022 outbreaks: a global case series.
    Lancet. 2022 Nov 17:S0140-6736(22)02187-0. doi: 10.1016/S0140-6736(22)02187.
    PubMed     Abstract available
    
    
    
62. GOODALL RL, Meredith SK, Nunn AJ, Bayissa A, et al
    Evaluation of two short standardised regimens for the treatment of rifampicin-resistant tuberculosis (STREAM stage 2): an open-label, multicentre, randomised, non-inferiority trial.
    Lancet. 2022 Nov 7. pii: S0140-6736(22)02078.
    PubMed     Abstract available
    
    
    
63. JACKSON S, Kabir Z, Comiskey C
    Divergence in pace of decline in tuberculosis rates among migrants versus non-migrants in Ireland from 2011 to 2020.
    Lancet. 2022;400 Suppl 1:S52.
    PubMed     Abstract available
    
    
    October 2022
64. MYERS B, Lombard CJ, Lund C, Joska JA, et al
    Comparing dedicated and designated approaches to integrating task-shared psychological interventions into chronic disease care in South Africa: a three-arm, cluster randomised, multicentre, open-label trial.
    Lancet. 2022;400:1321-1333.
    PubMed     Abstract available
    
    
    
65. PAN D, Sze S, Nazareth J, Martin CA, et al
    The monkeypox case definition in the UK is broad - Authors' reply.
    Lancet. 2022;400:1301-1302.
    PubMed    
    
    
    
66. KIRBY T
    Anthony Fauci: moving on.
    Lancet. 2022;400:1182-1183.
    PubMed    
    
    
    September 2022
67. LUO R, Fong Y, Boeras D, Jani I, et al
    The clinical effect of point-of-care HIV diagnosis in infants: a systematic review and meta-analysis.
    Lancet. 2022;400:887-895.
    PubMed     Abstract available
    
    
    
68. TECHNAU KG, Mazanderani AH
    Point-of-care HIV diagnosis for infants: the outcomes we need to achieve.
    Lancet. 2022;400:864-865.
    PubMed    
    
    
    August 2022
69. THORNTON J
    Botswana's HIV/AIDS success.
    Lancet. 2022;400:480-481.
    PubMed    
    
    
    
70. TARIN-VICENTE EJ, Alemany A, Agud-Dios M, Ubals M, et al
    Clinical presentation and virological assessment of confirmed human monkeypox virus cases in Spain: a prospective observational cohort study.
    Lancet. 2022 Aug 8. pii: S0140-6736(22)01436.
    PubMed     Abstract available
    
    
    July 2022
71. MAYER KH, Phanuphak N, Mgodi N, Grinsztejn B, et al
    New HIV prevention approaches: promise, praxis, and pitfalls.
    Lancet. 2022;400:257-259.
    PubMed    
    
    
    
72. 
    Population-level risks of alcohol consumption by amount, geography, age, sex, and year: a systematic analysis for the Global Burden of Disease Study 2020.
    Lancet. 2022;400:185-235.
    PubMed     Abstract available
    
    
    
73. BOOTH A
    New HIV law welcomed in Argentina.
    Lancet. 2022;400:149.
    PubMed    
    
    
    
74. GOGA A, Bekker LG, Garrett N, Reddy T, et al
    Breakthrough SARS-CoV-2 infections during periods of delta and omicron predominance, South Africa.
    Lancet. 2022 Jul 6. pii: S0140-6736(22)01190.
    PubMed    
    
    
    June 2022
75. CHARANI E, McKee M, Balasegaram M, Mendelson M, et al
    Global burden of antimicrobial resistance: essential pieces of a global puzzle.
    Lancet. 2022;399:2346-2347.
    PubMed    
    
    
    
76. PAN D, Sze S, Nazareth J, Martin CA, et al
    Monkeypox in the UK: arguments for a broader case definition.
    Lancet. 2022 Jun 15. pii: S0140-6736(22)01101.
    PubMed    
    
    
    May 2022
77. NELLUMS LB, Latif A, Nkhoma K, Timmons S, et al
    COVID-19 boosters and building trust among UK minority ethnic communities.
    Lancet. 2022 May 25. pii: S0140-6736(22)00945.
    PubMed    
    
    
    
78. 
    Measuring the availability of human resources for health and its relationship to universal health coverage for 204 countries and territories from 1990 to 2019: a systematic analysis for the Global Burden of Disease Study 2019.
    Lancet. 2022 May 23. pii: S0140-6736(22)00532.
    PubMed     Abstract available
    
    
    
79. WATTS G
    Luc Antoine Montagnier.
    Lancet. 2022;399:1862.
    PubMed    
    
    
    April 2022
80. BUCHBINDER SP, McElrath MJ, Dieffenbach C, Corey L, et al
    COVID-19 vaccination and HIV-1 acquisition - Authors' reply.
    Lancet. 2022;399:e36.
    PubMed    
    
    
    
81. LOGUNOV DY, Livermore DM, Ornelles DA, Bayer W, et al
    COVID-19 vaccination and HIV-1 acquisition.
    Lancet. 2022;399:e34-e35.
    PubMed    
    
    
    
82. BLAKNEY AK, Bekker LG
    DNA vaccines join the fight against COVID-19.
    Lancet. 2022;399:1281-1282.
    PubMed    
    
    
    
83. MUDZINGWA EK, Parker IK
    Long-acting injections for HIV prevention among women in sub-Saharan Africa.
    Lancet. 2022 Apr 1. pii: S0140-6736(22)00613.
    PubMed    
    
    
    
84. DELANY-MORETLWE S, Hughes JP, Bock P, Ouma SG, et al
    Cabotegravir for the prevention of HIV-1 in women: results from HPTN 084, a phase 3, randomised clinical trial.
    Lancet. 2022 Apr 1. pii: S0140-6736(22)00538.
    PubMed     Abstract available
    
    
    March 2022
85. KRAUSE PR, Rees H, Figueroa JP, Swaminathan S, et al
    Booster vaccines for COVID-19 vaccine breakthrough cases? - Authors' reply.
    Lancet. 2022;399:1225.
    PubMed    
    
    
    
86. WATERS L, Marra F, Pozniak A, Cockburn J, et al
    Ritonavir and COVID-19: pragmatic guidance is important.
    Lancet. 2022 Mar 22. pii: S0140-6736(22)00280.
    PubMed    
    
    
    
87. BEKKER LG, Garrett N, Goga A, Fairall L, et al
    Effectiveness of the Ad26.COV2.S vaccine in health-care workers in South Africa (the Sisonke study): results from a single-arm, open-label, phase 3B, implementation study.
    Lancet. 2022;399:1141-1153.
    PubMed     Abstract available
    
    
    
88. 
    Progress in health among regions of Ethiopia, 1990-2019: a subnational country analysis for the Global Burden of Disease Study 2019.
    Lancet. 2022 Mar 11. pii: S0140-6736(21)02868.
    PubMed     Abstract available
    
    
    
89. FALLAH MP, Reinhart E
    Apartheid logic in global health.
    Lancet. 2022;399:902-903.
    PubMed    
    
    
    February 2022
90. CHEMAITELLY H, Abu-Raddad LJ
    Waning effectiveness of COVID-19 vaccines.
    Lancet. 2022;399:771-773.
    PubMed    
    
    
    
91. MADHI SA, Ihekweazu C, Rees H, Pollard AJ, et al
    Decoupling of omicron variant infections and severe COVID-19.
    Lancet. 2022 Feb 18. pii: S0140-6736(22)00109.
    PubMed    
    
    
    
92. MINALGA B, Chung C, Davids JD, Martin A, et al
    Research on transgender people must benefit transgender people.
    Lancet. 2022;399:628.
    PubMed    
    
    
    
93. SIVA N
    Gilead and ViiV Healthcare reach settlement over HIV drug.
    Lancet. 2022;399:618.
    PubMed    
    
    
    
94. HUMPHREYS K, Shover CL, Andrews CM, Bohnert ASB, et al
    Responding to the opioid crisis in North America and beyond: recommendations of the Stanford-Lancet Commission.
    Lancet. 2022;399:555-604.
    PubMed    
    
    
    
95. BEYRER C
    Archbishop Desmond Tutu and the universality of health and human rights.
    Lancet. 2022;399:503-504.
    PubMed    
    
    
    
96. VAN DER MERWE LL, Cloete A, Skinner D
    How HIV advocacy can be used to ensure quality transgender health care: lessons from South Africa.
    Lancet. 2022 Feb 4. pii: S0140-6736(22)00177.
    PubMed    
    
    
    January 2022
97. WOLTER N, Jassat W, Walaza S, Welch R, et al
    Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa: a data linkage study.
    Lancet. 2022 Jan 19. pii: S0140-6736(22)00017.
    PubMed     Abstract available
    
    
    
98. MCCALL C
    Disrupted care in Papua New Guinea: the harms of COVID-19.
    Lancet. 2022;399:226-227.
    PubMed    
    
    
    December 2021
99. HOSSEINPOOR AR, Bergen N, Kirkby K, Schlotheuber A, et al
    Monitoring inequalities is a key part of the efforts to end AIDS, tuberculosis, and malaria.
    Lancet. 2021 Dec 8. pii: S0140-6736(21)02756.
    PubMed    
    
    
    
100. MENDELSON M, Venter F, Moshabela M, Gray G, et al
     The political theatre of the UK's travel ban on South Africa.
     Lancet. 2021 Dec 3. pii: S0140-6736(21)02752.
     PubMed    
     
     
     November 2021
101. SIMBAYI LC, Moyo S, van Heerden A, Zuma K, et al
     Global HIV efforts need to focus on key populations in LMICs.
     Lancet. 2021 Nov 29. pii: S0140-6736(21)02692.
     PubMed    
     
     
     
102. JOLLY J
     A reproductive justice response to HIV/AIDS and COVID-19.
     Lancet. 2021;398:1958-1959.
     PubMed    
     
     
     
103. LANE R
     Pascale Ondoa: strengthening laboratory medicine in Africa.
     Lancet. 2021;398:1955.
     PubMed    
     
     
     
104. FALCARO M, Castanon A, Ndlela B, Checchi M, et al
     The effects of the national HPV vaccination programme in England, UK, on cervical cancer and grade 3 cervical intraepithelial neoplasia incidence: a register-based observational study.
     Lancet. 2021 Nov 3. pii: S0140-6736(21)02178.
     PubMed     Abstract available
     
     
     October 2021
105. 
     Global, regional, and national mortality among young people aged 10-24 years, 1950-2019: a systematic analysis for the Global Burden of Disease Study 2019.
     Lancet. 2021;398:1593-1618.
     PubMed     Abstract available
     
     
     
106. ADEPOJU P
     Nkengasong tipped to lead PEPFAR.
     Lancet. 2021;398:e15.
     PubMed    
     
     
     July 2021
107. SAMARASEKERA U
     Etheldreda Nakimuli-Mpungu: innovator in mental health.
     Lancet. 2021;398:109.
     PubMed    
     
     

Thank you for your interest in scientific medicine.

AMEDEO HIV Infection is free of charge.